The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

August 31, 2013

Conditions
Renal Function DisorderHemodynamic Instability
Interventions
DRUG

Dexmedetomidine

a loading dose of 1 µg kg-1 dexmedetomidine (Precedex Abbott Labs, North Chicago, IL) IV given over 10 minutes, followed by 0.5 µg kg-1 hour-1 IV dexmedetomidine infusion were administered. Dexmedetomidine was prepared as a 1 µg ml-1 solution using D5 0.3% NaCl solution.

DRUG

Ketamine

ketamine was bolused with 1 mg kg-1(IV) and followed by 1 mg kg-1 hour-1 ketamine IV infusion during the procedure.

DRUG

Propofol

propofol was bolused 1 mg kg-1 and 50 µg kg-1 min-1 propofol (IV) infusion during the procedure.

All Listed Sponsors
lead

TC Erciyes University

OTHER

NCT01948336 - The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients | Biotech Hunter | Biotech Hunter